Correlation Between NYSE Composite and Recursion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Recursion Pharmaceuticals, you can compare the effects of market volatilities on NYSE Composite and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Recursion Pharmaceuticals.
Diversification Opportunities for NYSE Composite and Recursion Pharmaceuticals
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between NYSE and Recursion is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of NYSE Composite i.e., NYSE Composite and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between NYSE Composite and Recursion Pharmaceuticals
Assuming the 90 days trading horizon NYSE Composite is expected to generate 2.7 times less return on investment than Recursion Pharmaceuticals. But when comparing it to its historical volatility, NYSE Composite is 8.97 times less risky than Recursion Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 806.00 in Recursion Pharmaceuticals on September 1, 2024 and sell it today you would lose (99.00) from holding Recursion Pharmaceuticals or give up 12.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Recursion Pharmaceuticals
Performance |
| Timeline |
NYSE Composite and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Recursion Pharmaceuticals
Pair trading matchups for Recursion Pharmaceuticals
Pair Trading with NYSE Composite and Recursion Pharmaceuticals
The main advantage of trading using opposite NYSE Composite and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.| NYSE Composite vs. Acumen Pharmaceuticals | NYSE Composite vs. Mind Medicine | NYSE Composite vs. NL Industries | NYSE Composite vs. Ecovyst |
| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |